Name : MRS.
KAVITHA OC-055 Referred By : MDU-WALK IN
Id : OAPT-2405 Ordered On : 28/01/2025 07:32
Age : 35 years Collected On : 28/01/2025 07:35
Gender : F Reported On : 29/01/2025 07:46
Phone : 9025444439 Vid : OP2425-2421
TEST RESULT UNITS Biological Reference Interval
ORBITO CHAKRA
DEPARTMENT OF HAEMATOLOGY - BLOOD (EDTA)
COMPLETE BLOOD COUNT -5 P
Total RBC Count 4.51 Million/μL 3.80 - 4.80 Million/μL
(Method: Impedence)
Haemoglobin-HB 12.6 g/dL 12 - 15 g/dL
(Method: Colorimetric Method)
PCV (Haematocrit) 38.1 % 36 - 46 %
(Method: Calculated)
MCV (Mean Corpuscular Volume) 84.5 fL 83 - 101 fL
(Method: Calculated)
MCH (Mean Corpuscular Haemoglobin) 27.9 pg 27 - 32 pg
(Method: Calculated)
MCHC (Mean Corpuscular Haemoglobin 33.1 g/dL 31.5 - 34.5 g/dL
Concentration)
(Method: Calculated)
Red Cell Distribution Width SD 42.4 fL 39 - 46 fL
(Method: Calculated)
Red Cell Distribution Width CV 14.2 % 11.5 - 15 %
(Method: Calculated)
Total WBC Count 7500 cells/cumm 4000 - 10000 cells/cumm
(Method: Flow Cytometry)
Differential Count
(Method: Flow Cytometry)
Neutrophils 58 % 40 - 80 %
Lymphocytes 32 % 20 - 40 %
Eosinophils 04 % 1-6 %
Monocytes 06 % 2 - 10 %
Basophils 00 % <2 %
N/L Ratio 1.81 . 1-3 .
Page 1 of 8
Name : MRS. KAVITHA OC-055 Referred By : MDU-WALK IN
Id : OAPT-2405 Ordered On : 28/01/2025 07:32
Age : 35 years Collected On : 28/01/2025 07:35
Gender : F Reported On : 29/01/2025 07:46
Phone : 9025444439 Vid : OP2425-2421
TEST RESULT UNITS Biological Reference Interval
Absolute Neutrophil Count 4350.0 cells/micro L 2000 - 7000 cells/micro L
(Method: Calculation)
Absolute Lymphocyte Count 2400.0 cells/micro L 1000 - 3000 cells/micro L
(Method: Calculation)
Absolute Eosinophil Count 300.0 cells/micro L 20 - 500 cells/micro L
(Method: Calculation)
Absolute Monocyte Count 450.0 cells/micro L 200 - 1000 cells/micro L
(Method: Calculation)
Absolute Basophil Count 0.0 cells/micro L 20 - 100 cells/micro L
(Method: Calculation)
Platelet Count 448 Thousand/μL 150 - 450 Thousand/μL
(Method: Impedance)
Plateletcrit 42.6 ⇈ % 19.7 - 42.4 %
(Method: Calculation)
Mean Platelet volume 9.5 fL 6.5 - 12.0 fL
(Method: Calculation)
Platelet distribution width-SD 11.5 fL FL
(Method: Calculation)
Platelet to large cell ratio (PLCR) 20.7 % 19.7 - 42.4 %
(Method: Calculation)
Platelet distribution width-CV 93 % %
(Method: Calculation)
DEPARTMENT OF BIOCHEMISTRY - FLUORIDE PLASMA
Blood Glucose Fasting 114.0 ⇈ mg/dL Hypoglycemia: < 73 mg/dL
(Method: GOD-POD) Normal: 74 - 100 mg/dL
Pre Diabetes: 101 - 125
mg/dL
Diabetes: > 125 mg/dL
INTERPRETATION
Most glucose strips and meters quantify whole blood glucose, whereas most laboratories use plasma or serum which reads 10-15%
higher.Blood samples in which serum is not separated from blood cells shows glucose values decreasing at rate of 3-5% per hour at
room temperature.Strenuous exercise, strong emotions, shock, burns and infections can increase glucose physiologically.Low
oxygen content (e.g,venous blood, high altitudes >3000 mts) gives falsely increased values.
HbA1c
(Method: HPLC)
Glycosylated Haemoglobin-HbA1c 6.2 ⇈ % Impaired glucose tolerance:
5.8 - 6.4 %
Diabetes: > 6.5 %
Non diabetic Level: < 5.70 %
Page 2 of 8
Name : MRS. KAVITHA OC-055 Referred By : MDU-WALK IN
Id : OAPT-2405 Ordered On : 28/01/2025 07:32
Age : 35 years Collected On : 28/01/2025 07:35
Gender : F Reported On : 29/01/2025 07:46
Phone : 9025444439 Vid : OP2425-2421
TEST RESULT UNITS Biological Reference Interval
Mean Plasma Glucose (MPG) 143.4 mg/dl
Estimated Average Glucose (eAG) 131.2 mg/dl
INTERPRETATION
HbA1c level reflects the mean glucose concentration over the previous period (approximately 6-8 weeks) and provides a much better
indication of long term glycemic control than blood and urine glucose determinations. The American Diabetes Association
recommends measurement of HbA1c every 3 months to determine whether a patient’s metabolic control has remained continuously
within the target range.A1C test should be performed at least 2 times a year in patients who are meeting treatment goals (and who
have stable glycemic control). A1C test should be performed quarterly in patients whose therapy has changed or who are not
meeting glycemic goals. Predicting development and progression of diabetic microvascular complications. This assay is not useful in
determining day to day glucose control and should not be used to replace routine blood glucose testing.
LIPID PROFILE
Total Cholesterol 213.0 ⇈ mg/dL Borderline High: 200 - 239
(Method: CHOD - PAP) mg/dL
High: > 239 mg/dL
Desirable: < 200 mg/dL
Triglycerides 95.0 mg/dL Normal: < 150 mg/dL
(Method: GPO/TOPS) High: 150 - 199 mg/dL
Hypertriglyceridemic: 200 -
499 mg/dL
Very High: > 500 mg/dL
HDL Cholesterol-Direct 52.5 mg/dL > 40 mg/dL
(Method: Selective Inhibition)
LDL Cholesterol 141.5 ⇈ mg/dL Optimal: < 100 mg/dL
(Method: Calculation) Near optimal/above optimal:
100 - 129 mg/dL
Borderline high: 130 - 159
mg/dL
High: 160 - 189 mg/dL
Very high: > 190 mg/dL
Non HDL Cholesterol 160.5 ⇈ mg/dL < 140 mg/dL
(Method: Calculation)
VLDL 19.0 mg/dL < 35 mg/dL
(Method: Calculation)
LDL / HDL Ratio 2.7 High risk: More than - 6.0
(Method: Calculation) Borderline: 3.0 - 4.0
Optimal: Less than - 3.0
Cholesterol / Hdl Ratio 4.1 3.9 - 5
(Method: Calculation)
TGL / HDL Ratio 1.8 <2
(Method: Calculation)
Page 3 of 8
Name : MRS. KAVITHA OC-055 Referred By : MDU-WALK IN
Id : OAPT-2405 Ordered On : 28/01/2025 07:32
Age : 35 years Collected On : 28/01/2025 07:35
Gender : F Reported On : 29/01/2025 07:46
Phone : 9025444439 Vid : OP2425-2421
TEST RESULT UNITS Biological Reference Interval
LIVER FUNCTION TEST
Bilirubin Total 0.52 mg/dL < 1.2 mg/dL
(Method: MODIFIED TAB)
Bilirubin Direct 0.24 mg/dL < 0.40 mg/dL
(Method: MODIFIED TAB)
Bilirubin Indirect 0.28 mg/dL 0.25 - 1 mg/dL
(Method: Calculation)
SGOT (AST) 13.0 U/L < 31 U/L
(Method: IFCC / Kinetic)
SGPT (ALT) 20.0 U/L < 34 U/L
(Method: Enzymatic Method)
Alkaline Phosphatase 95.0 U/L 42 - 98 U/L
(Method: Kinetic IFCC)
Gamma GT 23.6 IU/L 5 - 32 IU/L
(Method: Szasz methodology)
Total Protein 7.6 g/dL 6.0 - 8.0 g/dL
(Method: Biuret)
Albumin 4.5 g/dL 3.5 - 5.2 g/dL
(Method: Bromocresol Green (BCG))
Globulin 3.1 g/dL 2.3 - 3.5 g/dL
(Method: Calculation)
AST/ALT Ratio 0.65
(Method: Calculation)
A/G Ratio 1.45 1-2
(Method: Calculation)
INTERPRETATION
Most causes of liver cell injury are associated with a greater increase in ALT than AST; however, an AST to ALT ratio of 2:1 or
greater is suggestive of alcoholic liver disease, particularly in the setting of an elevated gamma-glutamyl transferase.
RENAL FUNCTION TEST (RFT-5)
Urea 26.3 mg/dL 13 - 43 mg/dL
(Method: Urease / GLDH)
Page 4 of 8
Name : MRS. KAVITHA OC-055 Referred By : MDU-WALK IN
Id : OAPT-2405 Ordered On : 28/01/2025 07:32
Age : 35 years Collected On : 28/01/2025 07:35
Gender : F Reported On : 29/01/2025 07:46
Phone : 9025444439 Vid : OP2425-2421
TEST RESULT UNITS Biological Reference Interval
Creatinine 0.74 mg/dL 0.6 - 1.2 mg/dL
(Method: Enzymatic)
BUN-Blood Urea Nitrogen 12.27 mg/dL 6 - 20 mg/dL
(Method: Urease / GLDH)
BUN Creatinine Ratio 16.58
(Method: Calculation)
Glomerular Fitration Rate (eGFR) 116 ml/min/1.73 Normal (MDRD): > 60
(Method: Calculated) m2 ml/min/1.73 m2
GOUT MARKER
Uric Acid 5.99 mg/dL 2.3 - 6.6 mg/dL
(Method: Uricase - PAP)
INTERPRETATION
The concentration of uric acid in the blood usually increases in cases of gout, obesity, heart failure, kidney failure, hypothyroidism, psoriasis, and pre-eclampsia, etc.
MINERAL SCREEN
Calcium 10.11 mg/dL 8.6 - 10.2 mg/dL
(Method: Arsenazo III)
Magnesium 1.89 mg/dL 1.6 - 2.6 mg/dL
(Method: Xylidyl blue with ATCS)
Phosphorous 3.89 mg/dL 2.5 - 4.5 mg/dL
(Method: Phosphomolybdate)
IRON DEFICIENCY PROFILE (1)
Iron 42.8 ⇊ ug/dL 50 - 170 ug/dL
(Method: Spectrophotometry)
DEPARTMENT OF IMMUNOLOGY - SERUM
FREE THYROID PROFILE
Free T3 2.98 pg/mL 2.1 - 4.4 pg/mL
(Method: CLIA)
Page 5 of 8
Name : MRS. KAVITHA OC-055 Referred By : MDU-WALK IN
Id : OAPT-2405 Ordered On : 28/01/2025 07:32
Age : 35 years Collected On : 28/01/2025 07:35
Gender : F Reported On : 29/01/2025 07:46
Phone : 9025444439 Vid : OP2425-2421
TEST RESULT UNITS Biological Reference Interval
Free T4 1.2 ng/dL 0.8 - 2.7 ng/dL
(Method: CLIA)
TSH (Thyroid Stimulating Hormone) 3.58 uIU/mL 0.35 - 5.55 uIU/mL
(Method: CLIA)
INTERPRETATION
Above the normal value based upon the age group.TSH Levels are subjected to circadian variations reaching peak levels between
2-4 am and at a minimum between 6-10 pm.The variation is of order of 50% hence time of day has influence of TSH measurements.
TSH values < 0.03 u/l/ml need to be clinically correlated due to presence of rare TSH variant in some individuals.Pregnancy : First
trimester : 0.3 - 4.5, Second trimester: 0.5 - 4.6, Third trimester : 0.8 - 5.2. This test is used for Primary hypothyroid, TSH secretion,
Non thyroidal illness, Auto immune thyroid disease, Pregnancy associated thyroid disorder.
HORMONE
Testosterone 12.54 ⇊ ng/dl 15 - 70 ng/dl
(Method: CLIA)
VITAMINS (B12 & D)
Vitamin B - 12 439 pg/ml 206 - 678 pg/ml
(Method: CLIA)
INTERPRETATION
Low vitamin B12 values may cause megaloblastic anemia and/or peripheral neuropathies.A normal serum concentration of vitamin
B12 does not rule out tissue deficiency of Vitamin B12.If clinical symptoms suggest deficiency, measurement of Homocysteine
should be considered even if serum vitamin B12 concentrations are normal. Patients taking Vitamin B12 may have misleading
results. Many other conditions are known to cause an increase (vitamin C, vitamin A, estrogens, hepatocellular injury,
myeloproliferative disorders,uremia) or decrease (pregnancy,smoking, hemodialysis, multiple myeloma) serum levels.
Vitamin D Total - 25 Hydroxy 18.6 ⇊ ng/mL Deficiency: < 10 ng/mL
Cholecalciferol Insufficiency: 10 - 30 ng/mL
(Method: CLIA) Toxicity: > 100 ng/mL
Sufficiency: 30 - 100 ng/mL
INTERPRETATION
A steroid hormone that has long been known for its important role in regulating body levels of calcium and phosphorus and in the
mineralization of bone. The level of 25 hydroxy vitamin D reflects the overall vitamin D nutritional status of an individual.Decreased
level may be seen in dietary deficiency, malabsorption, liver disease, nephrotic syndrome and in patients receiving medications that
accelerate the metabolism of vitamin D. Elevated levels may be seen in patients with excess intake of vitamin D.Differential
diagnosis of causes of Rickets and Osteomalacia. Monitoring Vitamin D replacement therapy
IMMUNOGLOBULIN E (Ig E) 166.3 ⇈ IU/mL < 160 IU/mL
(Method: CLIA)
INTERPRETATION
Measurement of concentration of IgE in serum is useful in the initial evaluation of patients suspected of having an allergic disease.
Above normal concentration of IgE in serum are stron gly associated with allergic disease.
Measurement of serum IgE along with the multi-allergen IgE antibody offers greater sensitivity for the detection of allergic disease
than either test alone.
DEPARTMENT OF CLINICAL PATHOLOGY - URINE
Page 6 of 8
Name : MRS. KAVITHA OC-055 Referred By : MDU-WALK IN
Id : OAPT-2405 Ordered On : 28/01/2025 07:32
Age : 35 years Collected On : 28/01/2025 07:35
Gender : F Reported On : 29/01/2025 07:46
Phone : 9025444439 Vid : OP2425-2421
TEST RESULT UNITS Biological Reference Interval
Urine Routine
(Method: MANUAL)
Physical Examination
Colour PALE YELLOW
Appearance SLIGHTLY TURBID
Biochemical Examination
Specific Gravity 1.025 1.003 - 1.030
pH 5.0 4.7 - 7.5
Protein NEGATIVE
Glucose NEGATIVE
Nitrite NEGATIVE
Bilirubin NEGATIVE
Ketone NEGATIVE
Blood NEGATIVE
Microscopic Examination
Pus cells 4-6 cells/hpf < 5 cells/hpf
Epithelial Cells 3-5 cells/hpf < 5 cells/hpf
RBC 1-2 cells/hpf
Crystals NIL
Mucus ABSENT
Casts NIL
Bacteria NOT PRESENT
Others NIL
--- End of the Report ---
Page 7 of 8
Name : MRS. KAVITHA OC-055 Referred By : MDU-WALK IN
Id : OAPT-2405 Ordered On : 28/01/2025 07:32
Age : 35 years Collected On : 28/01/2025 07:35
Gender : F Reported On : 29/01/2025 07:46
Phone : 9025444439 Vid : OP2425-2421
TEST RESULT UNITS Biological Reference Interval
Dr. ANUSHA.G MBBS. MD
Consultant Pathologist.
APPROVED BY
Page 8 of 8